PIN66 COST-EFFECTIVENESS ANALYSIS OF CEFTAZIDIME-AVIBACTAM VERSUS COLISTIN-MEROPENEM IN THE TREATMENT OF INFECTIONS DUE TO CARBAPENEM-RESISTANT ENTEROBACTERIACEAE IN COLOMBIA
F.A. Varon(Fundación Neumológica Colombiana), Elkin Lemos, J.M. Reyes Sanchez, N. Castaño Gamboa(Pfizer (United Kingdom))
Cited by 1
Related Papers
Use of healthcare resources in a cohort of rheumatoid arthritis patients treated with biological disease-modifying antirheumatic drugs or tofacitinib
|Clinical Rheumatology|2020|9
PCN210 RESOURCE UTILIZATION AND COST FOR WOMEN WITH ADVANCED HR+/HER2- BREAST CANCER IN COLOMBIAN HEALTH CARE SETTINGS
|Value in Health|2019|6
Budget Impact Analysis of Anticoagulation Clinics in Patients with Atrial Fibrillation under Chronic Therapy with Oral Anticoagulants
|Journal of Primary Care & Community Health|2021|3
Management Costs of Febrile Neutropenia in Oncology Patients in Colombia
|Research Square|2021|1